Caught Between Stewardship and Resistance: How to Treat Acute Complicated Diverticulitis in Areas of Low Antimicrobial Susceptibility?
2024

Treating Complicated Diverticulitis in Areas with Low Antibiotic Effectiveness

Sample size: 69 publication 10 minutes Evidence: moderate

Author Information

Author(s): Enciu Octavian, Toma Elena-Adelina, Miron Adrian, Popa Gabriela Loredana, Muntean Andrei-Alexandru, Porosnicu Andrei Ludovic, Popa Mircea Ioan, Modun Darko, Maresca Marc

Primary Institution: University of Medicine and Pharmacy Carol Davila

Hypothesis

How often and what types of multidrug-resistant bacteria occur in patients undergoing emergency surgery for complicated acute diverticulitis?

Conclusion

The study found a high prevalence of multidrug-resistant bacteria in patients with complicated diverticulitis, highlighting the need for tailored antibiotic therapy based on local resistance patterns.

Supporting Evidence

  • 43.9% of Escherichia coli strains were multidrug-resistant.
  • 80% of Klebsiella pneumoniae strains were extended-spectrum beta-lactamase positive.
  • 57.14% of Enterococcus spp. were vancomycin-resistant.

Takeaway

This study looked at patients with a serious gut problem and found that many had bacteria that don't respond to common antibiotics, so doctors need to choose treatments carefully.

Methodology

The study was a prospective cohort observational study that enrolled patients admitted for emergency surgery for complicated acute diverticulitis from 2020 to 2023.

Potential Biases

Selection bias may have occurred due to unreported differences in patient comorbidities and the varying experience of surgical teams.

Limitations

The study was conducted during the COVID-19 pandemic, which may have affected treatment protocols and patient enrollment.

Participant Demographics

Most participants were women (55.1%) with an average age of 60.51 years.

Statistical Information

P-Value

p = 0.004

Confidence Interval

95% C.I.: 2.017–53.471

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/antibiotics13121150

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication